Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC

PaperCitations, authors & open-access status

Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 336 citations, 2020 year and hybrid oa status.

336
Citations
2020
Year
hybrid
OA Status

Related on ScholarIQ

Xiuning Le
Author
Jonathan W. Goldman
Author
John V. Heymach
Author
Edward B. Garon
Author
Journal of Thoracic Oncology
Journal
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account